南京科佰生物科技有限公司官方网站欢迎您的光临！
免费咨询热线： 4008-750-250
科研细胞
药靶细胞
标准品
NGS靶向捕获探针
CCDC6-RET [V804L]/BaF3
| CBP73215 | |
| I. Introduction | |
| Cell Line Name： | CCDC6-RET [V804L]/BaF3 |
| Host Cell: | BA/F3 |
| Stability: | 16 passages (in-house test, that not means the cell line will be instable beyond the passages we tested.) |
| Application: | Anti-proliferation assay and PD assay |
| Freeze Medium: | 90% FBS+10% DMSO |
| Complete Culture Medium: | RPMI-1640+10%FBS+1ug/ml puromycin |
| Mycoplasma Status: | Negative |
| II.Background | |
|
CCDC6, coiled-coil domain containing 6, has been shown to play a role in the DNA damaging signaling pathway acting as a substrate of ATM (PMID: 17420723). CCDC6 fusions with RET (PMID: 23154560, PMID: 26078337) and BRAF (PMID: 26314551) have been observed in multiple cancer types. |
|
| III. Representative Data | |
|
1.WB of CCDC6-RET V804L/BaF3
|
|
|
2. Sanger of CCDC6-RET [V804L]/BaF3
Figure 2. Breakpoint of CCDC6-RET V804L/BaF3
Figure 3. Point mutation of CCDC6-RET V804L/BaF3 |
|
|
3. Anti-proliferation assay
Figure 4. Anti-proliferation assay of one reference compounds on the CCDC6-RET V804L/BaF3 Stable Cell Line. |
|
扫一扫，关注我们公众号
Copyright ©2021 www.cobioer.com All Rights Reserved. 南京科佰生物科技有限公司版权所有 苏ICP备13038923号